|
C7ORF28A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.766300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.086830E-01 |
| Normal-vs-Stage2 |
1.284310E-02 |
| Normal-vs-Stage3 |
7.856600E-03 |
| Normal-vs-Stage4 |
1.301150E-01 |
| Stage1-vs-Stage2 |
8.027500E-02 |
| Stage1-vs-Stage3 |
6.172400E-02 |
| Stage1-vs-Stage4 |
7.228600E-01 |
| Stage2-vs-Stage3 |
7.446000E-01 |
| Stage2-vs-Stage4 |
2.819000E-01 |
| Stage3-vs-Stage4 |
3.436800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.056400E-03 |
| Normal-vs-AfricanAmerican |
2.586200E-01 |
| Normal-vs-Asian |
9.335800E-01 |
| Caucasian-vs-AfricanAmerican |
5.827800E-01 |
| Caucasian-vs-Asian |
1.019880E-02 |
| AfricanAmerican-vs-Asian |
2.452000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.224400E-02 |
| Normal-vs-Female |
3.348300E-02 |
| Male-vs-Female |
8.249600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.918190E-01 |
| Normal-vs-Age(41-60Yrs) |
2.260300E-02 |
| Normal-vs-Age(61-80Yrs) |
1.164100E-03 |
| Normal-vs-Age(81-100Yrs) |
5.375800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.097600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.464200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.214400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.282400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.677900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.497700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.950400E-02 |
| Classical-VS-Follicular |
1.459800E-02 |
| Classical-VS-Other |
2.590600E-01 |
| Classical-VS-Normal |
1.447230E-01 |
| Tall-VS-Follicular |
7.770600E-01 |
| Tall-VS-Other |
9.045400E-01 |
| Tall-VS-Normal |
1.517560E-02 |
| Follicular-VS-Other |
7.665400E-01 |
| Follicular-VS-Normal |
4.001000E-03 |
| Other-VS-Normal |
9.539800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.749910E-02 |
| Normal-vs-N1 |
1.469180E-01 |
| N0-vs-N1 |
5.171800E-01 |
|
|
